Form D Buzzer: Seventh Sense Biosystems $12.75 million Financing. HOWARD WEISMAN Released Nov 16 SEC Filing

Biotechnology Seventh Sense Biosystems, Inc. - HOWARD WEISMAN

Seventh Sense Biosystems Financing

Seventh Sense Biosystems, Inc., Corporation just released form D for $12.75 million equity financing. This is a new filing. Seventh Sense Biosystems was able to finance itself with $5.50 million so far. That is 43.14% of the fundraising offer. The total private offering amount was $12.75 million. The private financing document was filed on 2016-11-16. The reason for the financing was: unspecified. The fundraising still has about $7.25 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Seventh Sense Biosystems is based in Massachusetts. The filler’s business is Biotechnology. The form was filed by HOWARD WEISMAN PRESIDENT AND CHIEF EXECUTIVE OFFICER. The company was incorporated more than five years ago. The filler’s address is: 200 Boston Avenue, Suite 3700, Medford, Ma, Massachusetts, 02155. Howard Weisman is the related person in the form and it has address: C/O Seventh Sense Biosystems, Inc., 200 Boston Avenue, Suite 3700, Cambridge, Ma, Massachusetts, 02155. Link to Seventh Sense Biosystems Filing: 000145171816000004.

Analysis of Seventh Sense Biosystems Offering

On average, firms in the Biotechnology sector, sell 73.77% of the total offering amount. Seventh Sense Biosystems sold 43.14% of the offering. The fundraising is still open. The average investment floor size for companies in the Biotechnology industry is $3.08 million. The total amount raised is 78.57% bigger than the average for companies in the Biotechnology sector. The minimum investment for this financing was set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Seventh Sense Biosystems Also

The Form D signed by HOWARD WEISMAN might help Seventh Sense Biosystems, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment